The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
CHOLECALCIFEROL and SODIUM FLUORIDE · CHOLECALCIFEROL 400 [iU]/mL; SODIUM FLUORIDE .25 mg/mL · Liquid · Oral · BonGeo Pharmaceuticals, Inc.
NDC 52796-0172-50 · 1 BOTTLE, DROPPER in 1 BOX / 50 mL in 1 BOTTLE, DROPPER · UNAPPROVED DRUG OTHER · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| BonGeo Pharmaceuticals, Inc. | CHOLECALCIFEROL 400 [iU]/mL; SODIUM FLUORIDE .25 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Floriva — NDC 52796-0172-50," retrieved September 3, 2026, https://drugdashboards.com/drug/52796017250.
Free to cite with attribution — see how the data is put together.